Magnetic Insight Raises $17M Series B to Expand Magnetic Particle Imaging and Monitoring Technology into Clinical Applications

News
2022
2021
Archive

April 19, 2022

Cidara Therapeutics and Mundipharma to Present Results from Global Phase 3 ReSTORE Trial of Rezafungin for the Treatment of Candidemia and/or Invasive Candidiasis at ECCMID 2022
April 12, 2022

Radionetics Oncology Appoints Nishan de Silva, M.D. as Chief Executive Officer
April 11, 2022

Artiva Biotherapeutics Announces Agreement with Merck to Evaluate Combinations of NK Cells with Tri-Specific NK-Cell Engagers
April 4, 2022

Rallybio Appoints Christine A. Nash and Hui Liu, Ph.D., to Its Board of Directors
April 4, 2022

5AM Ventures Closes $750 Million Across Two Life Science Funds and Announces Team Additions
March 31, 2022

Cidara Therapeutics Announces the Completion of Dosing the First Cohort of Healthy Volunteers in the Phase 1 Trial of CD388 in Development for Universal Prevention and Treatment of Seasonal and Pandemic Influenza
March 31, 2022

Crinetics Pharmaceuticals Reports Positive Top-Line Results From CRN04777 Phase 1 Study Multiple-Ascending Dose Cohorts
March 30, 2022

Scientist.com Expands Science as a Service® Platform with Acquisition of Notch8
March 25, 2022

Leading U.S. Fertility Clinics Adopt New TMRW Technology for Safe Management of Frozen Eggs and Embryos; 12 Additional Clinics Onboard Revolutionary Specimen Management Platform
March 25, 2022

Pear Therapeutics Joins Epic App Orchard to Enable Clinicians to Monitor Prescription Digital Therapeutics

© 2022 5AM Venture Management LLC